A Clinical Trial to Evaluate the Safety and Efficacy of 20 ml Cerebrolysin in Patients With Vascular Dementia

Clinical trial NCT00947531 · COMPLETED

Trial details

NCT number: NCT00947531
Sponsor: Ever Neuro Pharma GmbH
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Vascular Dementia

Start date: 2006-10-01
Enrollment: 242

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.